-
公开(公告)号：WO2004058305A2
公开(公告)日：2004-07-15
申请号：PCT/CA0302008
申请日：2003-12-24
Applicant: AN GO GEN INC , STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ
Inventor： STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ
CPC classification number: A61K9/5036 , A61K35/12 , C12N5/0656 , C12N5/0663 , C12N11/04 , C12N2533/52 , C12N2533/56 , C12N2533/76
Abstract: Cell therapy comprises encapsulating a cell with an integrin or other cell interaction factor, for administration to a mammal. The cells may express a therapeutic transgene or the cells may be regenerative.
Abstract translation: 细胞疗法包括用整联蛋白或其它细胞相互作用因子包封细胞，用于给予哺乳动物。 细胞可以表达治疗性转基因，或细胞可以是再生的。
-
公开(公告)号：CA2383093A1
公开(公告)日：2001-03-29
申请号：CA2383093
申请日：1999-09-23
Applicant: AN GO GEN INC
Inventor： STEWART DUNCAN J
IPC: A61K35/36 , A61K35/28 , A61K35/33 , A61K38/18 , A61K48/00 , A61P9/12 , A61P11/00 , C07K14/52 , C12N5/10 , C12N15/09
Abstract: Cell-based gene transfer is effected by administering transfected fibroblast cells, from dermal or other origins, containing an expressible transgene coding for an angiogenic factor or other therapeutic factor, into the pulmonary circulation of a patient, where the cells express and secrete expression products of the transgene to act locally at the site of expressio n, and in some cases to be conveyed by the patient's circulation to other body organs. The process is especially useful in treatment of pulmonary hypertension by means of expressed angiogenic factors.
-
-
-
-
Patent Agency Ranking
公开(公告)号：AU2003294541A1
公开(公告)日：2004-07-22
申请号：AU2003294541
申请日：2003-12-24
Applicant: STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ , AN GO GEN INC
Inventor： STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ
Abstract: Cell therapy comprises encapsulating a cell with an integrin or other cell interaction factor, for administration to a mammal. The cells may express a therapeutic transgene or the cells may be regenerative.
-
公开(公告)号：CA2450650A1
公开(公告)日：2004-05-26
申请号：CA2450650
申请日：2003-12-24
Applicant: AN GO GEN INC
Inventor： KAROUBI GOLNAZ , STEWART DUNCAN J , COURTMAN DAVID
IPC: A61K9/50 , A61K35/12 , C12N5/077 , C12N5/0775 , C12N11/04 , A61K47/42 , A61K48/00 , A61K47/36 , A61K9/48 , A61K9/66
Abstract: Cell therapy comprises encapsulating a cell with an integrin or other cell interaction factor, for administration to a mammal. The cells may express a therapeutic transgene or the cells may be regenerative.
-
-
公开(公告)号：CA2450650C
公开(公告)日：2007-08-28
申请号：CA2450650
申请日：2003-12-24
Applicant: AN GO GEN INC
Inventor： KAROUBI GOLNAZ , COURTMAN DAVID , STEWART DUNCAN J
IPC: A61K9/50 , A61K35/12 , A61K47/36 , A61K47/42 , A61K48/00 , A61P11/00 , C12N5/077 , C12N5/0775 , C12N11/04 , C12N15/88
Abstract: Cell therapy comprises encapsulating a cell with an integrin or other cell interaction factor, for administration to a mammal. The cells may express a therapeutic transgene or the cells may be regenerative.
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.021 seconds)
